Sfoglia per Autore
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion
2013-01-01 Guocan Wang;Andrea Lunardi;Jiangwen Zhang;Zhenbang Chen;Ugo Ala;Kaitlyn A Webster;Yvonne Tay;Enrique Gonzalez-Billalabeitia;Ainara Egia;David R Shaffer;Brett Carver;Xue-Song Liu;Riccardo Taulli;Winston Patrick Kuo;Caterina Nardella;Sabina Signoretti;Carlos Cordon-Cardo;William L Gerald;Pier Paolo Pandolfi
From pseudo-ceRNAs to circ-ceRNAs: a tale of cross-talk and competition
2013-01-01 Riccardo Taulli;Cristian Loretelli;Pier Paolo Pandolfi
Characterization and Analysis of the Composition and Dynamics of the Mammalian Riboproteome
2013-01-01 Markus Reschke;John G. Clohessy;Nina Seitzer;Daniel P. Goldstein;Susanne B. Breitkopf;Daniel B. Schmolze;Ugo Ala;John M. Asara;Andrew H. Beck;Pier Paolo Pandolfi
Role of LRF/Pokemon in lineage fate decisions.
2013-01-01 Lunardi A;Guarnerio J;Wang G;Maeda T;Pandolfi PP
“Snorkeling” for missing players in cancer
2012-01-01 Riccardo Taulli;Pier Paolo Pandolfi
Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein α activity: implications in myelodysplastic syndrome and acute myeloid leukemia.
2012-01-01 Khanna-Gupta A;Abayasekara N;Levine M;Sun H;Virgilio M;Nia N;Halene S;Sportoletti P;Jeong JY;Pandolfi PP;Berliner N
A metabolic prosurvival role for PML in breast cancer.
2012-01-01 Carracedo A;Weiss D;Leliaert AK;Bhasin M;de Boer VC;Laurent G;Adams AC;Sundvall M;Song SJ;Ito K;Finley LS;Egia A;Libermann T;Gerhart-Hines Z;Puigserver P;Haigis MC;Maratos-Flier E;Richardson AL;Schafer ZT;Pandolfi PP
Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer.
2012-01-01 Juvekar A;Burga LN;Hu H;Lunsford EP;Ibrahim YH;Balmañà J;Rajendran A;Papa A;Spencer K;Lyssiotis CA;Nardella C;Pandolfi PP;Baselga J;Scully R;Asara JM;Cantley LC;Wulf GM
Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development.
2012-01-01 Tsuji-Takechi K; Negishi-Koga T; Sumiya E; Kukita A; Kato S; Maeda T; Pandolfi PP; Moriyama K; Takayanagi H.
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia.
2012-01-01 Noguera NI;Song MS;Divona M;Catalano G;Calvo KL;García F;Ottone T;Florenzano F;Faraoni I;Battistini L;Colombo E;Amadori S;Pandolfi PP;Lo-Coco F
A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance.
2012-01-01 Ito K;Carracedo A;Weiss D;Arai F;Ala U;Avigan DE;Schafer ZT;Evans RM;Suda T;Lee CH;Pandolfi PP
Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor.
2012-01-01 Syed F;Sherris D;Paus R;Varmeh S;Pandolfi PP;Bayat A
Acetylation-dependent regulation of Skp2 function.
2012-01-01 Inuzuka H;Gao D;Finley LW;Yang W;Wan L;Fukushima H;Chin YR;Zhai B;Shaik S;Lau AW;Wang Z;Gygi SP;Nakayama K;Teruya-Feldstein J;Toker A;Haigis MC;Pandolfi PP;Wei W
Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression.
2012-01-01 Papa A;Cordon-Cardo C;Bernardi R;Pandolfi PP
The ceRNA world: a new way of looking at the role of different RNA molecules
2012-01-01 U. Ala; F. Karreth; C. Bosia; A. Pagnani; R. Taulli; Y. Tay; F. Di Cunto; P. Provero; R. Zecchina; P.P. Pandolfi
Functional Antagonism between Sall4 and Plzf Defines Germline Progenitors
2012-01-01 Robin M. Hobbs; Sharmila Fagoonee; Antonella Papa; Kaitlyn Webster; Fiorella Altruda; Ryuichi Nishinakamura; Li Chai; Pier Paolo Pandolfi
Functional Connection between Rad51 and PML in Homology-Directed Repair
2011-01-01 Boichuk S; Hu L; Makielski K; Pandolfi PP; Gjoerup OV
Haplo-insufficiency: a driving force in cancer
2011-01-01 Berger AH; Pandolfi PP
Pro-senescence therapy for cancer treatment.
2011-01-01 Nardella C; Clohessy JG; Alimonti A; Pandolfi PP
Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors.
2011-01-01 Sasaki AT; Carracedo A; Locasale JW; Anastasiou D; Takeuchi K; Kahoud ER; Haviv S; Asara JM; Pandolfi PP; Cantley LC
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion | 2013 | Guocan Wang;Andrea Lunardi;Jiangwen Zhang;Zhenbang Chen;Ugo Ala;Kaitlyn A Webster;Yvonne Tay;Enrique Gonzalez-Billalabeitia;Ainara Egia;David R Shaffer;Brett Carver;Xue-Song Liu;Riccardo Taulli;Winston Patrick Kuo;Caterina Nardella;Sabina Signoretti;Carlos Cordon-Cardo;William L Gerald;Pier Paolo Pandolfi | |
| From pseudo-ceRNAs to circ-ceRNAs: a tale of cross-talk and competition | 2013 | Riccardo Taulli;Cristian Loretelli;Pier Paolo Pandolfi | |
| Characterization and Analysis of the Composition and Dynamics of the Mammalian Riboproteome | 2013 | Markus Reschke;John G. Clohessy;Nina Seitzer;Daniel P. Goldstein;Susanne B. Breitkopf;Daniel B. Schmolze;Ugo Ala;John M. Asara;Andrew H. Beck;Pier Paolo Pandolfi | |
| Role of LRF/Pokemon in lineage fate decisions. | 2013 | Lunardi A;Guarnerio J;Wang G;Maeda T;Pandolfi PP | |
| “Snorkeling” for missing players in cancer | 2012 | Riccardo Taulli;Pier Paolo Pandolfi | |
| Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein α activity: implications in myelodysplastic syndrome and acute myeloid leukemia. | 2012 | Khanna-Gupta A;Abayasekara N;Levine M;Sun H;Virgilio M;Nia N;Halene S;Sportoletti P;Jeong JY;Pandolfi PP;Berliner N | |
| A metabolic prosurvival role for PML in breast cancer. | 2012 | Carracedo A;Weiss D;Leliaert AK;Bhasin M;de Boer VC;Laurent G;Adams AC;Sundvall M;Song SJ;Ito K;Finley LS;Egia A;Libermann T;Gerhart-Hines Z;Puigserver P;Haigis MC;Maratos-Flier E;Richardson AL;Schafer ZT;Pandolfi PP | |
| Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer. | 2012 | Juvekar A;Burga LN;Hu H;Lunsford EP;Ibrahim YH;Balmañà J;Rajendran A;Papa A;Spencer K;Lyssiotis CA;Nardella C;Pandolfi PP;Baselga J;Scully R;Asara JM;Cantley LC;Wulf GM | |
| Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development. | 2012 | Tsuji-Takechi K; Negishi-Koga T; Sumiya E; Kukita A; Kato S; Maeda T; Pandolfi PP; Moriyama K; Takayanagi H. | |
| Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia. | 2012 | Noguera NI;Song MS;Divona M;Catalano G;Calvo KL;García F;Ottone T;Florenzano F;Faraoni I;Battistini L;Colombo E;Amadori S;Pandolfi PP;Lo-Coco F | |
| A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance. | 2012 | Ito K;Carracedo A;Weiss D;Arai F;Ala U;Avigan DE;Schafer ZT;Evans RM;Suda T;Lee CH;Pandolfi PP | |
| Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor. | 2012 | Syed F;Sherris D;Paus R;Varmeh S;Pandolfi PP;Bayat A | |
| Acetylation-dependent regulation of Skp2 function. | 2012 | Inuzuka H;Gao D;Finley LW;Yang W;Wan L;Fukushima H;Chin YR;Zhai B;Shaik S;Lau AW;Wang Z;Gygi SP;Nakayama K;Teruya-Feldstein J;Toker A;Haigis MC;Pandolfi PP;Wei W | |
| Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression. | 2012 | Papa A;Cordon-Cardo C;Bernardi R;Pandolfi PP | |
| The ceRNA world: a new way of looking at the role of different RNA molecules | 2012 | U. Ala; F. Karreth; C. Bosia; A. Pagnani; R. Taulli; Y. Tay; F. Di Cunto; P. Provero; R. Zecchina; P.P. Pandolfi | |
| Functional Antagonism between Sall4 and Plzf Defines Germline Progenitors | 2012 | Robin M. Hobbs; Sharmila Fagoonee; Antonella Papa; Kaitlyn Webster; Fiorella Altruda; Ryuichi Nishinakamura; Li Chai; Pier Paolo Pandolfi | |
| Functional Connection between Rad51 and PML in Homology-Directed Repair | 2011 | Boichuk S; Hu L; Makielski K; Pandolfi PP; Gjoerup OV | |
| Haplo-insufficiency: a driving force in cancer | 2011 | Berger AH; Pandolfi PP | |
| Pro-senescence therapy for cancer treatment. | 2011 | Nardella C; Clohessy JG; Alimonti A; Pandolfi PP | |
| Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors. | 2011 | Sasaki AT; Carracedo A; Locasale JW; Anastasiou D; Takeuchi K; Kahoud ER; Haviv S; Asara JM; Pandolfi PP; Cantley LC |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile